Steve Schonfeld’s Stemline Therapeutics, Inc. STML Stock Holding History

Steve Schonfeld’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-960,088	Closed	-$4.65M	–	1663
2020 Q1	$4.65M	Buy	960,088 +934,179	+3,606%	+$6.06M	0.29%	65
2019 Q4	$276K	Sell	25,909 -40,491	-61%	-$402K	0.01%	1017
2019 Q3	$691K	Sell	66,400 -524,000	-89%	-$6.86M	0.02%	562
2019 Q2	$9.04M	Sell	590,400 -191,700	-25%	-$2.77M	0.32%	74
2019 Q1	$10.1M	Buy	+782,100	New	+$8.84M	0.35%	67

Steve Schonfeld's STML Position: Q2 2020 in Review

Steve Schonfeld sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 960,088 shares — an estimated $4.65M sold.

Steve Schonfeld first reported a position in STML in Q1 2019 and held it in 5 quarters. The position peaked at $10.1M in Q1 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

Steve Schonfeld reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Steve Schonfeld sold 960,088 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $4.65M.
Steve Schonfeld first reported a position in Stemline Therapeutics, Inc. in Q1 2019 and held it in 5 quarters.
Steve Schonfeld's Stemline Therapeutics, Inc. position peaked at $10.1M in Q1 2019.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.